6/19 Late treatment study
, study not available yet (News) (not included in the study count)
NIH halts clinical trial of hydroxychloroquine
NIH halts clinical trial of hydroxychloroquine
NIH halts late stage trial reporting no harm and no benefit. 470 patients.
NIH et al., 6/19/2020, preprint, 1 author.
